Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product, Application & End-User The global endoscopic ultrasound market size was $901.14 million in 2021 and is predicted to reach $1544.59 million by 2030, representing a CAGR of 6.17% throughout the forecast period of 2021-2030. An endoscope is a thin, tube-like instrument that is inserted into the body to evaluate its vital insights. A specialized endoscope is implemented to produce detailed images of the lining of digestive tracts and nearby organs through high-frequency sound waves. Ultrasound can also be performed by inserting an endoscopic probe inside the bronchi, which is widely known as endobronchial ultrasound. Endoscopic Ultrasound Biopsy is the process where a doctor takes some fluid and tissue from the abdomen or chest for a thorough analysis. During an endoscopic ultrasound pancreas, the doctor inserts an endoscope down the throat and straight into the abdomen. An ultrasound device situated at the end of the tube emits sound waves that display images of the pancreas and nearby tissues. Approximately about 75 million endoscopies are performed in the United States each year, where 68% (51.5 million) are gastrointestinal endoscopies. EUS (Endoscopic Ultrasound System) is also widely used to diagnose gastrointestinal cancers, including liver, pancreatic, and other cancers. In 2018, gastrointestinal cancers accounted for up to 26% of the total number of cancer incidences and 35% of all cancer-related deaths worldwide. As per the American Cancer Society (ACS), pancreatic cancer is one of the major causes of death all across the globe. In 2016, approximately 53070 people in the United States were diagnosed with pancreatic cancer, and almost 41000 deaths were related to it. According to GLOBOCAN, in 2013, there were up to 782,000 new cases of liver cancer. COVID-19 Impact Analysis The sudden outbreak of the COVID-19 pandemic had a considerable amount of impact on the overall market. During the lockdown, endoscopic activities in the UK dropped down to as low as 5% of the pre-COVID levels, only increasing to 20% after 10 weeks. The detection rate of endoscopic cancer was reduced approximately by 58% worldwide. Market Dynamics: - Market Drivers: - The continuous rising prevalence of gastrointestinal diseases worldwide is one of the primary reasons for the growth of this endoscopic ultrasound market. Gastrointestinal diseases are one of the major reasons for death across the globe. In 2020, there will be approximately 4.8 million cases of gastrointestinal cancers and more than 3.4 million deaths worldwide. Restraints: - The biggest restraint of EUS is its inability to distinguish between benign and malignant tissues, thus resulting in over staging due to peritumoral inflammation. Opportunities: - The launching of highly modernized and upgraded procedures like EUS guided fine-needle aspiration (EUS-FNAC) has become one of the most popular treatment methods for gastrointestinal cancer across the world. It is expected to grow at an exponential rate in the future. Segments Analysis The industry is broadly segmented based On Products, Applications, End-User, and Regions. Based on Product: Endoscopes Ultrasound Probes Ultrasonic Processors Imaging Systems Needles Accessories Based on Applications: Oncology Upper GI Oncology Lower GI Oncology Pancreatic Conditions Others Based on End-User: Hospitals Ambulatory Surgery Centers Specialty Clinics Diagnostic Centers Regional Analysis North America US Mexico Canada Rest of North America Europe France U.K Switzerland Germany Finland Belgium Netherlands Russia Spain Turkey Italy Rest of Europe Asia Pacific China Japan South Korea India Malaysia Singapore Thailand Australia Indonesia Philippines Rest of Asia-Pacific LAMEA Brazil Argentina Uruguay Saudi Arabia Rest of LAMEA Based on Product, the ‘Endoscope’ segment accounted for the largest market share and is expected to grow at a CAGR of 9.37% from 2020 to 2028. A rapid increase in the number of echo-endoscopy procedures and rapid penetration of the key market players in highly developed countries are expected to boost the overall market. The ‘Ultrasound Probes’ statement is the fastest-growing segment owing to the introduction of high-frequency ultrasound probes and an abrupt increase of export and import activities. Based on Applications, the ‘Oncology’ Segment significantly dominated the endoscopic ultrasound market with a CAGR of 4.48% due to the adoption of accurate and minimally invasive diagnostic tools and the rising prevalence of gastrointestinal cancer. The End-user ‘Hospitals’ segment dominated the industry owing to the favorable health reimbursement for minimally invasive processes and the continuous increase in the number of qualified and trained endoscopists. In the United States, a typical endoscopy costs an average of USD 2750 and reaches up to USD 4800. Also, the cost of an EGD with endoscopic ultrasound ranges between USD 2513 to USD 3501. Based on ‘Regions,’ North America dominated the industry with overall revenue of USD 297 million in 2018 and will continue to do so during the forecasted period due to its high rate of growth in EUS procedures and advancement of technologies. In the United States, almost 18.1 million are performed each year, and the prevalence rate of chronic gastrointestinal diseases among people aged 65 and above is as high as 35%. The Asia Pacific is the fastest-growing region of this market owing to the continuous rise of the aged population and the increasing importance of early diagnosis of cancer in China, Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 901.14 million The revenue forecast in 2030 USD 1544.59 million Growth rate CAGR of approximately 6.17% The base year for estimation 2021 Historical data 2015 – 2019 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Applications, By End-User, By Region By Product Endoscopes, Ultrasound Probes, Ultrasonic Processors, Imaging Systems, Needles, Accessories By Applications Oncology, Upper GI Oncology, Lower GI Oncology, Pancreatic Conditions, Others By End-User Hospitals, Ambulatory Surgery Centers, Specialty Clinics, Diagnostic Centers By Region North America, Europe, Asia-Pacific, LAMEA. Country Scope U.S., Canada, France, Germany, the U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E., etc. Company Usability Profiles FUJIFILM Holdings Corporation, Olympus Corporation, Medtronic, Smith & Nephew, Huaco Healthcare Technologies Co. Ltd., Pentax Medical (HOYA), B. Braun, SonoScape Medical Corporation, Boston Scientific Corporation, Conmed Corporation, Cook Medical, Ethicon, Medi-Globe Corporation, Ethicon Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Competitive Landscape A thorough and detailed competitive landscape analysis provides the most adequate details regarding the major competitors that are prevailing in the overall industry environment. The comparison is performed based on the market capability, company overview, overall revenue generated, expenditure in R&D, global presence, production capacities, market initiatives, company financials, organization strengths and flaws, production sites and facilities, etc. The major players that are covered in the industry report are: FUJIFILM Holdings Corporation Olympus Corporation Medtronic Smith & Nephew Huaco Healthcare Technologies Co. Ltd. Pentax Medical (HOYA) B. Braun SonoScape Medical Corporation Boston Scientific Corporation Conmed Corporation Cook Medical Ethicon Medi-Globe Corporation Ethicon Recent Developments On June 2021, Olympus and Hitachi signed a long-term business alliance regarding EUS. Hitachi will continue to provide diagnostic ultrasound systems and their related parts that are used in EUS to Olympus under this contract. Recently Smith & Nephew endoscopy introduced World's 1st all-in-one, mobile endoscopic visualization system. the DYONICS Vision 111 Portable Endoscopy System combines proprietary, cutting-edge imaging and display technology for providing the medical community with an endoscopic visualization solution. Frequently Asked Question About This Report What is the endoscopic ultrasound market growth? The global endoscopic ultrasound market is expected to grow at a compound annual growth rate (CAGR) of 6.17% from 2021 to 2030 to reach USD1544.59 million by 2030. Which region is expected to hold the highest amount of share in the EUS market? North America is estimated to hold the largest share in the EUS market. What factors are expected to drive the EUS market? The continuous rising prevalence of gastrointestinal diseases all across the world is the most important factor that is fuelling the growth of this market over the forecasted period of 2020-2028. What are the current trends of the EUS market? The most widely known trend that is currently dominating the EUS market is EUS guided fine-needle aspiration (EUS-FNAC) procedure. Who all are the major players of the EUS market? The major players of the EUS market include Olympus Corporation, Medtronic, Cook Medical, Smith and Nephew, Boston Scientific Corp, etc. How big is the endoscopic ultrasound market? The global endoscopic ultrasound market size was $901.14 Mn in 2021 and is predicted to reach $1544.59 Mn by 2030, with a CAGR of 6.17%. What was the value of the north america market in 2020? In 2020, the total value of the north american market was USD 323 million. At what percentage of CAGR is the EUS market projected to grow over the forecasted period? The EUS market is projected to grow at a CAGR of 6.17% over the forecasted period of 2021-2030. . 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Endoscopic Ultrasound Market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Market, by region, 2021-2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Global Market, By Product, 2021-2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 Global Market, By End-User, 2021-2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Global Market, By Application, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2020) 5.11.2. Trends in Application (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Endoscopic Ultrasound Manufacturing Sites, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Endoscopes 7.3.1. Endoscopes market, 2021-2030 (USD Million) 7.4. Ultrasound Probes 7.4.1. Ultrasound Probes market, 2021-2030 (USD Million) 7.5. Ultrasonic Processors 7.5.1. Ultrasonic Processors market, 2021-2030 (USD Million) 7.6. Imaging Systems 7.6.1. Imaging Systems market, 2021-2030 (USD Million) 7.7. Needles 7.7.1. Needles market, 2021-2030 (USD Million) 7.8. Accessories 7.8.1. Accessories market, 2021-2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals 8.3.1. Hospitals market, 2021-2030 (USD Million) 8.4. Ambulatory Surgery Centers 8.4.1. Ambulatory Surgery Centers market, 2021-2030 (USD Million) 8.5. Specialty Clinics 8.5.1. Specialty Clinics market, 2021-2030 (USD Million) 8.6. Diagnostic Centers 8.6.1. Diagnostic Centers market, 2021-2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Oncology 9.3.1. Oncology market, 2021-2030 (USD Million) 9.3.2. Upper GI Oncology 9.3.3. Lower GI Oncology market, 2021-2030 (USD Million) 9.4. Pancreatic Conditions 9.4.1. Pancreatic Conditions market, 2021-2030 (USD Million) 9.5. Others 9.5.1. Others market, 2021-2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America Market, By Product, 2021-2030 (USD Million) 10.1.2. North America Market, By End-User, 2021-2030 (USD Million) 10.1.3. North America Market, by Application, 2021-2030 (USD Million) 10.1.4. North America Market, by Country, 2021-2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, By Product, 2021-2030 (USD Million) 10.1.4.1.2. U.S. Market, By End-User, 2021-2030 (USD Million) 10.1.4.1.3. U.S. Market, by Application, 2021-2030 (USD Million) 10.1.4.2.Canada 10.1.4.2.1. Canada Market, By Product, 2021-2030 (USD Million) 10.1.4.2.2. Canada Market, By End-User, 2021-2030 (USD Million) 10.1.4.2.3. Canada Market, by Application, 2021-2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, By Product, 2021-2030 (USD Million) 10.2.2. Europe Market, By End-User, 2021-2030 (USD Million) 10.2.3. Europe Market, by Application, 2021-2030 (USD Million) 10.2.4. Europe Market, by country, 2021-2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, By Product, 2021-2030 (USD Million) 10.2.4.1.2. U.K. Market, By End-User, 2021-2030 (USD Million) 10.2.4.1.3. U.K. Market, by Application, 2021-2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, By Product, 2021-2030 (USD Million) 10.2.4.2.2. Germany Market, By End-User, 2021-2030 (USD Million) 10.2.4.2.3. Germany Market, by Application, 2021-2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, By Product, 2021-2030 (USD Million) 10.2.4.3.2. France Market, By End-User, 2021-2030 (USD Million) 10.2.4.3.3. France Market, by Application, 2021-2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, By Product, 2021-2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, By End-User, 2021-2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, by Application, 2021-2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, By Product, 2021-2030 (USD Million) 10.3.2. Asia Pacific Market, By End-User, 2021-2030 (USD Million) 10.3.3. Asia Pacific Market, by Application, 2021-2030 (USD Million) 10.3.4. Asia Pacific Market, by country, 2021-2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, By Product, 2021-2030 (USD Million) 10.3.4.1.2. China Market, By End-User, 2021-2030 (USD Million) 10.3.4.1.3. China Market, by Application, 2021-2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, By Product, 2021-2030 (USD Million) 10.3.4.2.2. India Market, By End-User, 2021-2030 (USD Million) 10.3.4.2.3. India Market, by Application, 2021-2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan Market, By Product, 2021-2030 (USD Million) 10.3.4.3.2. Japan Market, By End-User, 2021-2030 (USD Million) 10.3.4.3.3. Japan Market, by Application, 2021-2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, By Product, 2021-2030 (USD Million) 10.3.4.4.2. South Korea Market, By End-User, 2021-2030 (USD Million) 10.3.4.4.3. South Korea Market, by Application, 2021-2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC Market, By Product, 2021-2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC Market, By End-User, 2021-2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC Market, by Application, 2021-2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, By Product, 2021-2030 (USD Million) 10.4.2. Latin America Market, By End-User, 2021-2030 (USD Million) 10.4.3. Latin America Market, by Application, 2021-2030 (USD Million) 10.4.4. Latin America Market, by country, 2021-2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, By Product, 2021-2030 (USD Million) 10.4.4.1.2. Brazil Market, By End-User, 2021-2030 (USD Million) 10.4.4.1.3. Brazil Market, by Application, 2021-2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, By Product, 2021-2030 (USD Million) 10.4.4.2.2. Mexico Market, By End-User, 2021-2030 (USD Million) 10.4.4.2.3. Mexico Market, by Application, 2021-2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America Market, By Product, 2021-2030 (USD Million) 10.4.4.3.2. Rest of the Latin America Market, By End-User, 2021-2030 (USD Million) 10.4.4.3.3. Rest of the Latin America Market, by Application, 2021-2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, By Product, 2021-2030 (USD Million) 10.5.2. MEA Market, By End-User, 2021-2030 (USD Million) 10.5.3. MEA Market, by Application, 2021-2030 (USD Million) 10.5.4. MEA Market, by Region, 2021-2030 (USD Million) 11. Competitive Landscape 11.1 FUJIFILM Holdings Corporation 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. Product Portfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. OLYMPUS CORPORATION 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. MEDTRONIC 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. SMITH & NEPHEW 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. HUACO HEALTHCARE TECHNOLOGIES CO. LTD 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Pentax Medical (HOYA) 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. B. Braun 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. SonoScape Medical Corporation. 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. Boston Scientific Corporation 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. Conmed Corporation 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. Cook Medical 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. Ethicon. 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. Medi-Globe Corporation 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development 11.14. Ethicon 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development List of Tables (64 Tables) TABLE 1. Endoscopic Ultrasound Market, By Product, 2021-2030 (USD Million) TABLE 2. Market FOR Endoscopes, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Ultrasound Probes, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR Ultrasonic Processors, BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Imaging Systems, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Needles, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR Accessories, BY REGION, 2021-2030 (USD Million) TABLE 8. Market, By End-User, 2021-2030 (USD Million) TABLE 9. Market FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Ambulatory Surgery Centers, BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR Specialty Clinics, BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Diagnostic Centers, BY REGION, 2021-2030 (USD Million) TABLE 13. Market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 14. Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 15. Market FOR Oncology, BY REGION, 2021-2030 (USD Million) TABLE 16. Market FOR Upper GI Oncology, BY REGION, 2021-2030 (USD Million) TABLE 17. Market FOR Lower GI Oncology, BY REGION, 2021-2030 (USD Million) TABLE 18. Market FOR Pancreatic Conditions, BY REGION, 2021-2030 (USD Million) TABLE 19. Market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 20. Market, BY REGION, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA Market, By Product, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 25. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 26. EUROPE Market, By Product, 2021-2030 (USD Million) TABLE 27. EUROPE Market, By End-User, 2021-2030 (USD Million) TABLE 28. EUROPE Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC Market, By Product, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 33. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 34. LAMEA Market, By Product, 2021-2030 (USD Million) TABLE 35. LAMEA Market, By End-User, 2021-2030 (USD Million) TABLE 36. LAMEA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 37. FUJIFILM Holdings Corporation: COMPANY SNAPSHOT TABLE 38. FUJIFILM Holdings Corporation: OPERATING SEGMENTS TABLE 39. OLYMPUS CORPORATION: COMPANY SNAPSHOT TABLE 40. OLYMPUS CORPORATION: OPERATING SEGMENTS TABLE 41. MEDTRONIC: COMPANY SNAPSHOT TABLE 42. MEDTRONIC: OPERATING SEGMENTS TABLE 43. SMITH & NEPHEW: COMPANY SNAPSHOT TABLE 44. SMITH & NEPHEW: OPERATING SEGMENTS TABLE 45. HUACO HEALTHCARE TECHNOLOGIES CO. LTD: COMPANY SNAPSHOT TABLE 46. HUACO HEALTHCARE TECHNOLOGIES CO. LTD: OPERATING SEGMENTS TABLE 47. Pentax Medical (HOYA): COMPANY SNAPSHOT TABLE 48. Pentax Medical (HOYA): OPERATING SEGMENTS TABLE 49. B. Braun: COMPANY SNAPSHOT TABLE 50. B. Braun: OPERATING SEGMENTS TABLE 51. SonoScape Medical Corporation: COMPANY SNAPSHOT TABLE 52. SonoScape Medical Corporation: OPERATING SEGMENTS TABLE 53. Boston Scientific Corporation: COMPANY SNAPSHOT TABLE 54. Boston Scientific Corporation: OPERATING SEGMENTS TABLE 55. Conmed Corporation: COMPANY SNAPSHOT TABLE 56. Conmed Corporation: OPERATING SEGMENTS TABLE 57. Cook Medical: COMPANY SNAPSHOT TABLE 58. Cook Medical: OPERATING SEGMENTS TABLE 59. Ethicon: COMPANY SNAPSHOT TABLE 60. Ethicon: OPERATING SEGMENTS TABLE 61. Medi-Globe Corporation: COMPANY SNAPSHOT TABLE 62. Medi-Globe Corporation: OPERATING SEGMENTS TABLE 63. Ethicon: COMPANY SNAPSHOT TABLE 64. Ethicon: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 14 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Endoscopic Ultrasound, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Endoscopic Ultrasound, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Endoscope to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 16 Oncology to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 17Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 18 North America region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview